Dr. Tefferi, of the Mayo Clinic, discusses key considerations for diagnosis and management of primary myelofibrosis with the hosts in this episode of “Blood Cancer Talks.”
Dr. Tefferi discusses risk stratification systems for primary myelofibrosis, a genetically inspired prognostic scoring system, Janus kinase inhibitors, allogeneic transplant considerations, and more.